Martin Erixon has extensive experience from the Medical/Pharmaceutical industry as well as from the Food Processing industry. Based on a Ph.D. in Chemistry from the University of Lund and a Master of Science, Martin Erixon has developed a successful career in large corporations such as Gambro (Baxter) and Tetra Pak, one of the largest food packaging companies in the world. He combines strong leadership with excellent communication skills and has successfully built relationships with different stakeholders both in Gambro (Baxter) and Tetra Pak. Martin Erixon is a highly motivated team player and negotiator, who strives to find the best solutions in business relationships. In his capacity as advisor to Hamlet Pharma, Martin Erixon has facilitated the discussions with external partners in recent years.

The current CEO Mats Persson will stay in the company and continue to support the clinical trial program. Mats Persson has made invaluable contributions to the the development of the company and of Alpha1H into a strong drug candidate for bladder cancer. We are particularly grateful to him for his leadership during the past five years.  

"We are delighted to announce that Martin Erixon is joining Hamlet Pharma", says Catharina Svanborg, Chairman of Hamlet Pharma AB.  We are also grateful that Mats Persson continues to support the company with his extensive experience.